Gesine Meyer-Rath, MD, PhD

Research Assistant Professor, Global Health
Gesine Meyer-Rath
(617) 414-1260gesine@bu.edu

Biography

Gesine Meyer-Rath is a Research Assistant Professor at the Center for Global Health and Development of the Boston University School of Public Health. She is a physician and health economist working on the economics of HIV and antiretroviral treatment in low- and middle-income countries. Her focus lies on modeling methods for economic evaluation, including infectious disease modeling and decision analysis, and translating research into recommendations for public policy. Before joining CGHD she has worked in the Pediatrics Department of Charité University Hospital Berlin and with the World Health Organization on the ChoICE team’s generalized cost-effectiveness analysis and the calculation of the cost of WHO’s ’3 by 5′ programme. Since 2006, she has been mainly based in Johannesburg, collecting data for her PhD in health economics at the London School of Hygiene and Tropical Medicine. She holds a MD/PhD in physiology from Free University Berlin.

Education

  • Free University of Berlin , PhD
  • Free University of Berlin , MD

Publications

  • Published on 10/20/2014

    Fox MP, Shearer K, Maskew M, Meyer-Rath G, Clouse K, Sanne I. Attrition through Multiple Stages of Pre-Treatment and ART HIV Care in South Africa. PLoS One. 2014; 9(10):e110252.

    Read at: PubMed
  • Published on 3/10/2014

    Iyer HS, Scott CA, Lembela Bwalya D, Meyer-Rath G, Moyo C, Bolton Moore C, Larson BA, Rosen S. Resource Utilization and Costs of Care prior to ART Initiation for Pediatric Patients in Zambia. AIDS Res Treat. 2014; 2014:235483.

    Read at: PubMed
  • Published on 1/9/2014

    Terris-Prestholt F, Foss AM, Cox AP, Heise L, Meyer-Rath G, Delany-Moretlwe S, Mertenskoetter T, Rees H, Vickerman P, Watts CH. Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices. BMC Infect Dis. 2014; 14(1):14.

    Read at: PubMed
  • Published on 12/10/2013

    Jeffrey W. Eaton, Nicolas A. Menzies, John Stover, Valentina Cambiano, Leonid Chindelevitch, Gesine Meyer-Rath et al:. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Global Health. 2013; 1(2):23-34.

    Read at: Custom
  • Published on 12/10/2013

    Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health. 2014 Jan; 2(1):e23-34.

    Read at: PubMed
  • Published on 7/1/2013

    Schnippel K, Long L, Meyer-Rath G, Sanne I, Rosen S, Stevens W. Impact and costs of algorithms for the diagnosis of adults with pulmonary tuberculosis in South Africa. S Afr Med J. 2013 Jul; 103(7):436.

    Read at: PubMed
  • Published on 6/28/2013

    Scott CA, Iyer H, Bwalya DL, McCoy K, Meyer-Rath G, Moyo C, Bolton-Moore C, Larson B, Rosen S. Retention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysis. PLoS One. 2013; 8(6):e67910.

    Read at: PubMed
  • Published on 3/1/2013

    Meyer-Rath G, Brennan AT, Fox MP, Modisenyane T, Tshabangu N, Mohapi L, Rosen S, Martinson N. Rates and cost of hospitalization before and after initiation of antiretroviral therapy in urban and rural settings in South Africa. J Acquir Immune Defic Syndr. 2013 Mar 1; 62(3):322-328.

    Read at: PubMed
  • Published on 1/14/2013

    Meyer-Rath G, Brennan A, Long L, Ndibongo B, Technau K, Moultrie H, Fairlie L, Coovadia A, Rosen S. Cost and outcomes of paediatric antiretroviral treatment in South Africa. AIDS. 2013 Jan 14; 27(2):243-50.

    Read at: PubMed
  • Published on 1/14/2013

    Schnippel K, Meyer-Rath G, Long L, Stevens WS, Sanne I, Rosen S. Diagnosing Xpert MTB/RIF negative TB: impact and cost of alternative algorithms for South Africa. S Afr Med J. 2013 Feb; 103(2):101-6.

    Read at: PubMed

View 9 more publications:View full profile at BUMC